Changes in Insulin Resistance in Healthy Volunteers on STRIBILD® Medication - A Controlled, Mono Center, Three-arm, Randomized Phase I Study.

Trial Profile

Changes in Insulin Resistance in Healthy Volunteers on STRIBILD® Medication - A Controlled, Mono Center, Three-arm, Randomized Phase I Study.

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Nov 2014

At a glance

  • Drugs Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat (Primary) ; Darunavir; Emtricitabine/tenofovir disoproxil fumarate; Lopinavir/ritonavir; Ritonavir
  • Indications HIV infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Nov 2014 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
    • 06 Aug 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top